Top Biological Products, (No Diagnostic Substances) Stocks by Roiver Score™
The 96 Biological Products, (No Diagnostic Substances) companies we cover, ranked by the Roiver Score — a transparent 0–100 quality composite. Compugen Ltd leads with a score of 75.
| # | Company | Market cap | Score |
|---|---|---|---|
| 1 | CGENCompugen Ltd | $188M | 75Excellent |
| 2 | BKHABlack Hawk Acquisition Corporation Class A Ordinary Shares | $20M | 66Solid |
| 3 | NMRANeumora Therapeutics, Inc. Common Stock | $69M | 63Solid |
| 4 | BCRXBioCryst Pharmaceuticals Inc | $2.2B | 60Solid |
| 5 | GILDGilead Sciences Inc | $211.6B | 60Solid |
| 6 | EXELExelixis Inc | $17.2B | 57Solid |
| 7 | TECHBio-Techne Corp. | $11.4B | 52Solid |
| 8 | ELUTElutia Inc. Class A Common Stock | $37M | 50Solid |
| 9 | AMGNAmgen Inc | $251.9B | 50Solid |
| 10 | QGENQIAGEN N.V. | $10.4B | 49Mixed |
| 11 | ADMAADMA Biologics, Inc. | $2.6B | 48Mixed |
| 12 | BIIBBiogen Inc. Common Stock | $37.5B | 44Mixed |
| 13 | ATRAAtara Biotherapeutics, Inc | $80M | 40Mixed |
| 14 | NVAXNovavax Inc | $1.7B | 40Mixed |
| 15 | HALOHalozyme Therapeutics, Inc. | $14.9B | 40Mixed |
| 16 | KRYSKrystal Biotech, Inc. Common Stock | $9.8B | 40Mixed |
| 17 | NBIXNeurocrine Biosciences Inc | $14.9B | 40Mixed |
| 18 | RGENRepligen Corp | $11.2B | 28Mixed |
| 19 | CLDICalidi Biotherapeutics, Inc. | $2M | 25Mixed |
| 20 | KYTXKyverna Therapeutics, Inc. Common Stock | $351M | 25Mixed |
| 21 | SRRKScholar Rock Holding Corporation Common Stock | $5.3B | 23Weak |
| 22 | ABOSAcumen Pharmaceuticals, Inc. Common Stock | $15M | 23Weak |
| 23 | CVMCel-Sci Corporation | $24M | 22Weak |
| 24 | REPLReplimune Group, Inc. | $1.7B | 22Weak |
| 25 | MRNAModerna, Inc. Common Stock | $88.5B | 20Weak |
| 26 | PROKProKidney Corp. Class A Ordinary Shares | $271M | 20Weak |
| 27 | CRSPCRISPR Therapeutics AG | $5.0B | 20Weak |
| 28 | TARSTarsus Pharmaceuticals, Inc. Common Stock | $3.5B | 20Weak |
| 29 | RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock | $2.4B | 20Weak |
| 30 | MESOMesoblast Limited American Depositary Shares | $2.0B | 20Weak |
| 31 | TSHATaysha Gene Therapies, Inc. Common Stock | $1.3B | 20Weak |
| 32 | TCRXTScan Therapeutics, Inc. Common Stock | $12M | 20Weak |
| 33 | CGONCG Oncology, Inc. Common stock | $5.7B | 20Weak |
| 34 | FDMT4D Molecular Therapeutics, Inc. Common Stock | $657M | 20Weak |
| 35 | EVAXEvaxion A/S American Depositary Share | $26M | 20Weak |
| 36 | ALECAlector, Inc. Common Stock | $247M | 20Weak |
| 37 | XFORX4 Pharmaceuticals, Inc. Common Stock | $332M | 19Weak |
| 38 | KYMRKymera Therapeutics, Inc. Common Stock | $10.5B | 18Weak |
| 39 | ADPTAdaptive Biotechnologies Corporation Common Stock | $4.3B | 16Weak |
| 40 | SCLXScilex Holding Company Common Stock | $13M | 7Weak |
| 41 | BNTXBioNTech SE American Depositary Share | $22.1B | 6Weak |
| 42 | VCELVericel Corporation | $2.1B | 5Weak |
| 43 | VALNValneva SE American Depositary Shares | $517M | 4Weak |
| 44 | DNAGinkgo Bioworks Holdings, Inc. | $755M | 0Weak |
| 45 | OKYOOKYO Pharma Limited Ordinary Shares | $77M | 0Weak |
| 46 | DTILPrecision BioSciences, Inc. Common Stock | $195M | 0Weak |
| 47 | MGXMetagenomi Therapeutics, Inc. Common Stock | $29M | 0Weak |
| 48 | SCNIScinai Immunotherapeutics Ltd. American Depositary Shares | $638182 | 0Weak |
| 49 | EDITEditas Medicine, Inc. Common Stock | $410M | 0Weak |
| 50 | VIRVir Biotechnology, Inc. Common Stock | $1.9B | 0Weak |
| 51 | VORVor Biopharma Inc. Common Stock | $1.2B | 0Weak |
| 52 | AIMAIM ImmunoTech Inc. | $6M | 0Weak |
| 53 | INMBINmune Bio Inc. Common stock | $40M | 0Weak |
| 54 | IMCRImmunocore Holdings plc American Depositary Shares | $1.6B | 0Weak |
| 55 | RGNXREGENXBIO Inc. | $475M | 0Weak |
| 56 | LENZLENZ Therapeutics, Inc. Common Stock | $96M | 0Weak |
| 57 | TVGNTevogen Inc. Common Stock | $93M | 0Weak |
| 58 | CRBUCaribou Biosciences, Inc. Common Stock | $45M | 0Weak |
| 59 | OTLKOutlook Therapeutics, Inc. Common Stock | $114M | 0Weak |
| 60 | STROSutro Biopharma, Inc. | $151M | 0Weak |
| 61 | SRZNSurrozen, Inc. Common | $341M | 0Weak |
| 62 | SNTISenti Biosciences Holdings, Inc. Common Stock | $5M | 0Weak |
| 63 | ARMPArmata Pharmaceuticals, Inc. Common Stock | $122M | 0Weak |
| 64 | TWSTTwist Bioscience Corporation Common Stock | $10.1B | 0Weak |
| 65 | PLXProtalix BioTherapeutics, Inc. Common Stock | $209M | 0Weak |
| 66 | ALVOAlvotech Ordinary Shares | $1.7B | 0Weak |
| 67 | IBRXImmunityBio, Inc. Common Stock | $8.8B | 0Weak |
| 68 | OCGNOcugen, Inc. Common Stock | $238M | 0Weak |
| 69 | RLAYRelay Therapeutics, Inc. Common Stock | $4.0B | 0Weak |
| 70 | AUTLAutolus Therapeutics plc American Depositary Share | $405M | 0Weak |
| 71 | INBXInhibrx Biosciences, Inc. Common Stock | $1.1B | 0Weak |
| 72 | CSBRChampions Oncology, Inc. | $67M | 0Weak |
| 73 | VYGRVoyager Therapeutics, Inc. Common Stock | $106M | 0Weak |
| 74 | FATEFate Therapeutics, Inc. | $249M | 0Weak |
| 75 | CLLSCellectis S.A. American Depositary Shares | $109M | 0Weak |
| 76 | DBVTDBV Technologies S.A. American Depositary Shares | $596M | 0Weak |
| 77 | HUMAHumacyte, Inc. Common Stock | $114M | 0Weak |
| 78 | INKTMiNK Therapeutics, Inc. Common Stock | $54M | 0Weak |
| 79 | GLUEMonte Rosa Therapeutics, Inc. Common Stock | $918M | 0Weak |
| 80 | ATYRaTyr Pharma, Inc. Common Stock | $485M | 0Weak |
| 81 | BEAMBeam Therapeutics Inc. Common Stock | $2.8B | 0Weak |
| 82 | ACOGAlpha Cognition Inc. Common Stock | $190M | 0Weak |
| 83 | ELOXEloxx Pharmaceuticals, Inc. Common Stock | $46M | 0Weak |
| 84 | IPSCCentury Therapeutics, Inc. Common Stock | $266M | 0Weak |
| 85 | CRDFCardiff Oncology, Inc. Common Stock | $69M | 0Weak |
| 86 | IPHAInnate Pharma S.A. ADS | $163M | 0Weak |
| 87 | IVVDInvivyd, Inc. Common Stock | $171M | 0Weak |
| 88 | AGENAgenus Inc. | $309M | 0Weak |
| 89 | CCCCC4 Therapeutics, Inc. | $415M | 0Weak |
| 90 | LCTXLineage Cell Therapeutics, Inc. | $253M | 0Weak |
| 91 | ENTXEntera Bio Ltd. Ordinary Shares | $556M | 0Weak |
| 92 | ESLAEstrella Immunopharma, Inc. Common Stock | $28M | 0Weak |
| 93 | MGTXMeiraGTx Holdings plc Ordinary Shares | $911M | 0Weak |
| 94 | IOVAIovance Biotherapeutics, Inc. Common Stock | $3.8B | 0Weak |
| 95 | PRMEPrime Medicine, Inc. Common Stock | $856M | 0Weak |
| 96 | PLURPluri Inc. Common Stock | $16M | 0Weak |
Track biological products, (no diagnostic substances) quality
Follow these names, get weekly AI research digests, and see when their scores change.
Start free